A股異動 | 齊翔騰達(002408.SZ)漲超7% 10萬噸/年甲乙酮裝置檢修完成並恢復生產
格隆匯9月13日丨齊翔騰達(002408.SZ)高開高走,現報16.66元,漲7.48%,暫成交5億元,最新市值332億元。齊翔騰達上週五(10日)盤後公佈,公司於2021年8月7日披露了《關於10萬噸/年甲乙酮裝置例行檢修的公吿》,公司甲乙酮裝置運行及催化劑使用壽命已達週期上限,為確保甲乙酮裝置的安全、平穩運行,將按計劃進行例行停車檢修。截止該公吿披露日,淄博本部10萬噸/年甲乙酮裝置已完成檢修,現已恢復正常生產,並已進入穩定運行狀態。停車檢修期間公司對甲乙酮裝置進行了例行的催化劑的更換和設備的維護保養,確保了裝置的安全平穩長週期運行。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.